625 related articles for article (PubMed ID: 27483361)
21. Immunomodulatory Strategies for Huntington's Disease Treatment.
Colpo GD; Rocha NP; Stimming EF; Teixeira AL
CNS Neurol Disord Drug Targets; 2017; 16(8):936-944. PubMed ID: 28606048
[TBL] [Abstract][Full Text] [Related]
22. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
[TBL] [Abstract][Full Text] [Related]
23. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
24. Clinical and genetic data of Huntington disease in Moroccan patients.
Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
[TBL] [Abstract][Full Text] [Related]
25. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
[TBL] [Abstract][Full Text] [Related]
26. Neurocognitive signs in prodromal Huntington disease.
Stout JC; Paulsen JS; Queller S; Solomon AC; Whitlock KB; Campbell JC; Carlozzi N; Duff K; Beglinger LJ; Langbehn DR; Johnson SA; Biglan KM; Aylward EH
Neuropsychology; 2011 Jan; 25(1):1-14. PubMed ID: 20919768
[TBL] [Abstract][Full Text] [Related]
27. Huntington's disease in Turkey: genetic counseling, clinical features, and outcome.
Karadag YS; Cavdarli BE; Yuksel RN
Neurol Res; 2021 May; 43(5):381-386. PubMed ID: 33377823
[No Abstract] [Full Text] [Related]
28. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Huntington's disease gene CAG trinucleotide repeat alleles in patients with bipolar disorder.
Ramos EM; Gillis T; Mysore JS; Lee JM; Alonso I; Gusella JF; Smoller JW; Sklar P; MacDonald ME; Perlis RH
Bipolar Disord; 2015 Jun; 17(4):403-8. PubMed ID: 25726852
[TBL] [Abstract][Full Text] [Related]
30. The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease.
Ferreira-Correia A; Krause A; Anderson DG
J Huntingtons Dis; 2020; 9(4):325-334. PubMed ID: 33044188
[TBL] [Abstract][Full Text] [Related]
31. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
[TBL] [Abstract][Full Text] [Related]
32. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Moss DJH; Pardiñas AF; Langbehn D; Lo K; Leavitt BR; Roos R; Durr A; Mead S; ; ; Holmans P; Jones L; Tabrizi SJ
Lancet Neurol; 2017 Sep; 16(9):701-711. PubMed ID: 28642124
[TBL] [Abstract][Full Text] [Related]
33. Determinants of Onset of Huntington's Disease with Behavioral Symptoms: Insight from 92 Patients.
Lenka A; Kamble NL; Sowmya V; Jhunjhunwala K; Yadav R; Netravathi M; Kandasamy M; Moily NS; Purushottam M; Jain S; Pal PK
J Huntingtons Dis; 2015; 4(4):319-24. PubMed ID: 26682993
[TBL] [Abstract][Full Text] [Related]
34. Huntingtin gene CAG repeat numbers in Chinese patients with Huntington's disease and controls.
Jiang H; Sun YM; Hao Y; Yan YP; Chen K; Xin SH; Tang YP; Li XH; Jun T; Chen YY; Liu ZJ; Wang CR; Li H; Pei Z; Shang HF; Zhang BR; Gu WH; Wu ZY; Tang BS; Burgunder JM;
Eur J Neurol; 2014 Apr; 21(4):637-42. PubMed ID: 24471773
[TBL] [Abstract][Full Text] [Related]
35. Preliminary analysis of Huntington's Disease in South Korea.
Shin CW; Choi YJ; Kim M; Jeon BS
J Huntingtons Dis; 2013; 2(1):83-7. PubMed ID: 25063431
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
[TBL] [Abstract][Full Text] [Related]
37. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
[TBL] [Abstract][Full Text] [Related]
39. Clinical correlates of mitochondrial function in Huntington's disease muscle.
Turner C; Cooper JM; Schapira AH
Mov Disord; 2007 Sep; 22(12):1715-21. PubMed ID: 17557337
[TBL] [Abstract][Full Text] [Related]
40. Identification of extreme motor phenotypes in Huntington's disease.
Braisch U; Hay B; Muche R; Rothenbacher D; Landwehrmeyer GB; Long JD; Orth M;
Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):283-294. PubMed ID: 27868347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
